These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32298204)

  • 21. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Australian rubella serosurvey 2012-2013: On track for elimination?
    Edirisuriya C; Beard FH; Hendry AJ; Dey A; Gidding HF; Hueston L; Dwyer DE; Wood JG; Macartney KK; McIntyre PB
    Vaccine; 2018 May; 36(20):2794-2798. PubMed ID: 29661586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles and Rubella Seroprevalence Among Children and Adolescents of Córdoba, Argentina: A Cross-Section Study in the Context of the Elimination Program.
    Pedranti M; Isa MB; Riberi MI; Hernandez G; Alfaro J; Tenaglia M; Colazo Salbetti MB; Mladin JJ; Nates S; Adamo MP
    Viral Immunol; 2023; 36(6):429-434. PubMed ID: 37102675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
    Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
    AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Alleman MM; Wannemuehler KA; Hao L; Perelygina L; Icenogle JP; Vynnycky E; Fwamba F; Edidi S; Mulumba A; Sidibe K; Reef SE
    Vaccine; 2016 Dec; 34(51):6502-6511. PubMed ID: 27866768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts.
    Doshi S; Khetsuriani N; Zakhashvili K; Baidoshvili L; Imnadze P; Uzicanin A
    Int J Epidemiol; 2009 Feb; 38(1):182-91. PubMed ID: 19074954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.
    Cho HK; Lee H; Kim HW; Kim SS; Kang HJ; Kim IT; Kim KH
    J Korean Med Sci; 2016 Dec; 31(12):1957-1962. PubMed ID: 27822935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
    Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
    Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China.
    Sun X; Tang F; Hu Y; Deng X; Wang Z; Zhou M; Liu Y
    Hum Vaccin Immunother; 2020 Jul; 16(7):1738-1742. PubMed ID: 31977281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People's Democratic Republic.
    Hefele L; Xaydalasouk K; Kleine D; Homsana A; Xayavong D; Syphan S; Hübschen JM; Muller CP; Black AP
    Int J Infect Dis; 2021 Jul; 108():524-530. PubMed ID: 34119678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C; Mankertz A
    PLoS One; 2012; 7(8):e42867. PubMed ID: 22880124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space.
    Carcelen AC; Winter AK; Moss WJ; Chilumba I; Mutale I; Chongwe G; Monze M; Mulundu G; Nkamba H; Mwansa FD; Mulenga L; Rhoda DA; Hayford K; Mutembo S
    Sci Rep; 2022 Jun; 12(1):10217. PubMed ID: 35715547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.
    Izadi S; Zahraei SM; Mokhtari-Azad T
    Hum Vaccin Immunother; 2018 Jun; 14(6):1412-1416. PubMed ID: 29420120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009-2015.
    Getahun M; Beyene B; Gallagher K; Ademe A; Teshome B; Tefera M; Asha A; Afework A; Assefa E; HaileMariam Y; HaileGiorgis Y; Ketema H; Shiferaw D; Bekele A; Jima D; Kebede A
    BMC Public Health; 2016 Nov; 16(1):1168. PubMed ID: 27863513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.